Back to Agenda
Brexit and the European Network: 1,5 months to go! Where Do We Stand?
Session Chair(s)
Christa Wirthumer-Hoche, PhD
Chair, EMA Management Board, Head
Austrian Medicines & Medical Devices Agency (AGES), Austria
The session will discuss the challenges and solutions identified within the EU Regulatory Network on how to carry forward after the UK is no longer an official member of the European Union. It will discuss the tactical solutions put in place to continue operating without disturbance and also give advice to the industry on the expectations on them.
Speaker(s)
Panel Discussion
Kora H Doorduyn-van der Stoep, MSc, RPh
MEB, Netherlands
EU Representative
Panel Discussion
Tony Humphreys, MPharm
European Medicines Agency, Netherlands
Head of the Regulatory Science and Innovation Task Force
Panel Discussion
Hugo Hurts
Medicines Evaluation Board (MEB), Netherlands
Chair HMA Brexit Task Force; Executive Director
Panel Discussion
Nick Meade, MSc
Genetic Alliance UK, United Kingdom
Director of Policy
Panel Discussion
Lorraine Nolan, PhD
Health Products Regulatory Authority , Ireland
Chief Executive
Panel Discussion
Aimad Torqui
Medicines Evaluation Board, Netherlands
Division Head Medicines Evaluation Board
Have an account?